Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging.
about
Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review)Gene therapy for cardiovascular disease mediated by ultrasound and microbubbles.Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skippingSafety of AAV factor IX peripheral transvenular gene delivery to muscle in hemophilia B dogs.Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs.Transduction of skeletal muscles with common reporter genes can promote muscle fiber degeneration and inflammationTherapeutic approaches to muscular dystrophy.Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral VectorDuchenne muscular dystrophy gene therapy in the canine model.Immunosuppression decreases inflammation and increases AAV6-hSERCA2a-mediated SERCA2a expressionSuccessful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies.Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy.Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model.Preclinical studies for gene therapy of Duchenne muscular dystrophy.Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human Trials.Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?Repair or replace? Exploiting novel gene and cell therapy strategies for muscular dystrophies.Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophy.Fibrogenic Cell Plasticity Blunts Tissue Regeneration and Aggravates Muscular Dystrophy.
P2860
Q30397703-0B93661F-E654-46CE-8B06-3B86A50A7BDEQ30454594-05E4A932-345B-48AA-81A7-FAA5AE2EFA1FQ30514014-146889C9-EC26-4386-AADA-2E6596CD939BQ34025098-ED195E52-6564-41A8-BFDD-CF0A1C8A0385Q34080895-4DBBE47C-8F76-4E57-8D05-CA087D298D95Q34517044-AB030483-1593-4E5B-A3D7-27CACCCD26EAQ34982869-89A8C169-0A3E-4C86-99AE-28556A510985Q34994545-E4605E4A-15EF-4890-BCBA-43190B389AF3Q35513407-785B24CB-164E-4953-920A-8FA330771A7CQ35641673-AAC4B8E2-E051-4A8A-8ACD-01A21D5E3F23Q36114228-CC01CB36-0FF8-45D5-B132-457C7BD566B1Q36142496-A6CC00FB-044C-4281-8468-191648FA9CD6Q36861720-B3E92D28-BFD1-4520-8B22-5D72C9ECBC64Q37277411-59E62D4D-B495-4C1B-B7B4-53A964838CBFQ37548291-F3671B73-066B-44D7-B8BC-F63A33C39E0CQ37686976-A1AAF32B-F471-480E-895C-95308394D03DQ37760380-87582725-BE91-48D4-ABD5-FE2299C7E82EQ37943306-47A52CB5-4D64-4915-A267-41B4671D1481Q38014906-40B48DA0-0EAD-40A8-BC9C-23FE5BA9F03CQ38079633-BADE0C96-2DB6-4AEF-AF0B-C59102584FBFQ39392603-1D27C74D-745D-4397-ADAB-BBE941CE6CACQ42028126-ACD8ABFD-FEFC-417F-A5E3-B106C8974B16
P2860
Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Immune responses to AAV in can ...... ssays and noninvasive imaging.
@ast
Immune responses to AAV in can ...... ssays and noninvasive imaging.
@en
type
label
Immune responses to AAV in can ...... ssays and noninvasive imaging.
@ast
Immune responses to AAV in can ...... ssays and noninvasive imaging.
@en
prefLabel
Immune responses to AAV in can ...... ssays and noninvasive imaging.
@ast
Immune responses to AAV in can ...... ssays and noninvasive imaging.
@en
P2093
P2860
P356
P1433
P1476
Immune responses to AAV in can ...... ssays and noninvasive imaging.
@en
P2093
Andrea Arnett
Baocheng Chu
Carolina Berger
Donghoon Lee
James Allen
Jeffrey S Chamberlain
Martin J Kushmerick
Stanley R Riddell
Stephen J Tapscott
Zejing Wang
P2860
P304
P356
10.1038/MT.2009.294
P577
2009-12-29T00:00:00Z